Xenon Pharmaceuticals logo

Xenon Pharmaceuticals Share Price (NASDAQ: XENE)

$37.66

-0.57

(-1.49%)

Live

Last updated on

Check the interactive Xenon Pharmaceuticals Stock chart to analyse performance

Xenon Pharmaceuticals stock performance

as on August 19, 2025 at 12:43 AM IST

  • Today's Low:$37.27
    Today's High:$38.30

    Day's Volatility :2.69%

  • 52 Weeks Low:$26.74
    52 Weeks High:$46.00

    52 Weeks Volatility :41.87%

Xenon Pharmaceuticals Stock Returns

PeriodXenon Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
23.52%
2.3%
0.0%
6 Months
-2.35%
-5.8%
0.0%
1 Year
-3.39%
-10.9%
0.0%
3 Years
3.32%
2.8%
-11.6%

Xenon Pharmaceuticals Inc Key Stats

Check Xenon Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$38.23
Open
$37.91
Today's High
$38.3
Today's Low
$37.27
Market Capitalization
$2.8B
Today's Volume
$819.9K
52 Week High
$46.0
52 Week Low
$26.74
Revenue TTM
$7.5M
EBITDA
$-290.4M
Earnings Per Share (EPS)
$-3.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-31.6%

Stock Returns calculator for Xenon Pharmaceuticals Stock including INR - Dollar returns

The Xenon Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xenon Pharmaceuticals investment value today

Current value as on today

₹99,247

Returns

₹753

(-0.75%)

Returns from Xenon Pharmaceuticals Stock

₹4,827 (-4.83%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Xenon Pharmaceuticals Stock

400%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Xenon Pharmaceuticals Stock from India on INDmoney has increased by 400% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Xenon Pharmaceuticals Inc

  • Name

    Holdings %

  • FMR Inc

    10.80%

  • venBio Select Advisor LLC

    7.48%

  • Driehaus Capital Management LLC

    5.98%

  • Wellington Management Company LLP

    4.94%

  • HHG PLC

    4.33%

  • Capital Research & Mgmt Co - Division 3

    4.03%

Analyst Recommendation on Xenon Pharmaceuticals Stock

Rating
Trend

Buy

    95%Buy

    4%Hold

    0%Sell

Based on 24 Wall street analysts offering stock ratings for Xenon Pharmaceuticals(by analysts ranked 0 to 5 stars)

Xenon Pharmaceuticals Share Price Target

What analysts predicted

Upside of 46.05%

Target:

$55.00

Current:

$37.66

Xenon Pharmaceuticals share price target is $55.00, a slight Upside of 46.05% compared to current price of $37.66 as per analysts' prediction.

Xenon Pharmaceuticals Stock Insights

  • Price Movement

    In the last 7 days, XENE stock has moved up by 12.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 8.76K → 7.5M (in $), with an average increase of 64.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -65.04M → -84.70M (in $), with an average decrease of 30.2% per quarter
  • XENE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 66.6%
  • XENE vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 98.8%
  • Price to Sales

    ForXENE every $1 of sales, investors are willing to pay $398.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.6 for every $1 of sales.

Xenon Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Xenon Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Xenon Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Xenon Pharmaceuticals Inc logo
21.4%
-2.35%
-3.39%
3.32%
222.62%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
83.8%
36.85%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

Xenon Pharmaceuticals Dividend announcements

  • Xenon Pharmaceuticals Earnings

    Xenon Pharmaceuticals’s price-to-earnings ratio stands at None

About Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Organization
Xenon Pharmaceuticals
Employees
316
CEO
Ms. Andrea DiFabio J.D.
Industry
Health Technology

Key Management of Xenon Pharmaceuticals Inc

NameTitle
Ms. Andrea DiFabio J.D.
Chief Legal Officer & Corporate Secretary
Dr. Christopher John Kenney M.D.
Chief Medical Officer
Dr. Matthew D. Ronsheim Ph.D.
Chief Operating Officer
Ms. Shelley McClCoskey B.A.
Executive Vice President of Human Resources
Dr. Robin P. Sherrington Ph.D.
Executive Vice President of Strategy & Innovation
Dr. James R. Empfield Ph.D.
Executive Vice President of Drug Discovery
Mr. Darren S. Cline M.B.A.
Chief Commercial Officer and Member of Executive Team

Important FAQs about investing in XENE Stock from India :

What is Xenon Pharmaceuticals share price today?

Xenon Pharmaceuticals share price today is $37.66 as on . Xenon Pharmaceuticals share today touched a day high of $38.30 and a low of $37.27.

What is the 52 week high and 52 week low for Xenon Pharmaceuticals share?

Xenon Pharmaceuticals share touched a 52 week high of $46.00 and a 52 week low of $26.74. Xenon Pharmaceuticals stock price today, is trending at $37.66, lower by 18.13% versus the 52 week high.

How to invest in Xenon Pharmaceuticals Stock (XENE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xenon Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xenon Pharmaceuticals Shares that will get you 0.0398 shares as per Xenon Pharmaceuticals share price of $37.66 per share as on August 19, 2025 at 12:43 AM IST.

What is the minimum amount required to buy Xenon Pharmaceuticals Stock (XENE) from India?

Indian investors can start investing in Xenon Pharmaceuticals (XENE) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Xenon Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Xenon Pharmaceuticals share’s latest price of $37.66 as on August 19, 2025 at 12:43 AM IST, you will get 0.2655 shares of Xenon Pharmaceuticals. Learn more about fractional shares .

What are the returns that Xenon Pharmaceuticals has given to Indian investors in the last 5 years?

Xenon Pharmaceuticals stock has given 222.62% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?

Discover More